NCT02324127 Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer Status UNKNOWN Phase NA
NCT02321579 Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities Status UNKNOWN Phase NA
NCT02321202 Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer Status COMPLETED Phase PHASE4
NCT02292173 Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer Status COMPLETED Phase PHASE1
NCT02291133 Treatment of Primary Liver Tumors With Electrochemotherapy (ECT) Status COMPLETED Phase PHASE1/PHASE2
NCT02271646 Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation Status COMPLETED Phase NA
NCT02264886 Adaptive MRI-Guided SBRT for Unresectable Primary or Oligometastatic Central Thorax and Abdominal Malignancies Status COMPLETED Phase PHASE1
NCT02239900 Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02232490 Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L Status UNKNOWN Phase PHASE3
NCT02202564 Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT02202317 Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors Status COMPLETED Phase NA
NCT02185768 Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II Status COMPLETED Phase PHASE2
NCT02133079 Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96 Status UNKNOWN Phase PHASE1/PHASE2
NCT02069145 Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer Status COMPLETED Phase PHASE1
NCT02038296 Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma Status COMPLETED Phase PHASE3
NCT02029157 A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE3
NCT02013830 A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer Status COMPLETED Phase PHASE2